A glimpse of our research and the creative scientists we have supported.
Coming out of Northwestern University, this vaccine study will determine its effectiveness at battling prostate cancer.
Dr. Onn Brandman at Stanford Medical seeks to understand genes and the development process. He looks at ways to re-wire cancer cells to render them harmless.
At Scripps Research in California, Assistant Professor Michael Bollong is on the hunt for promising therapeutic molecules that increase the body’s natural capacity for repair. If successful, the activity of stem cells in the lungs will be augmented, repairing the underlying damage that causes pulmonary fibrosis.
Developing the Next-Generation of Synthetic Biologists
Northwestern University’s Center for Synthetic Biology is developing first-of-its-kind education and outreach materials. These assets will enable a new pedagogical approach for teaching and a new way of thinking for synthetic biologists of the future.
Dr. Ian Seiple, an associate professor at University of California-San Francisco, and his colleagues have demonstrated that the engineering of small molecular changes into some antibiotics can restore their effectiveness in stopping the growth of drug resistant bacteria. Now, they’re working to create new antibiotics for resistant Gram-negative infections.
At University of California-San Francisco, pediatric oncologist Dr. Beth Winger is studying protein mutation in cancer. If successful, her method will enable targeted therapies to be matched with newly discovered cancer-causing mutations, expanding targeted therapies to many more cancer patients.
The Cholangiocarcinoma Foundation is leading a collaborative, multi-center research grant process to explore and evaluate why some patients’ cholangiocarcinoma cancer develops immunotherapy resistance and then develop new approaches for individualized treatment.
The Bin Jiang lab at Northwestern University is working on developing techniques for intercellular mitochondrial transfer. Mitochondrial dysfunction contributes to many common disorders, including cardiovascular diseases, diabetes, neurodegeneration, and aging, but treatment is currently unavailable to restore mitochondrial function.
